Skip to content

News Release: Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update

New Blog: Explore an example of agentic rational design using Anthropic’s Claude in “Less is More: Refactoring the CAR Signaling Domain”

Announcement: Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics for Metabolic Diseases

Announcement: Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors

Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors

LinkedIn
X
YouTube

Presentations & Publications

GB-0895 COPD Phase 1 study ERS Barcelona 2026

09.08.2026

Download as PDF

Now we can.

Generate:Biomedicines
101 South Street, Suite 900
Somerville, MA 02143
United States

© 2026 Generate:Biomedicines

LinkedIn
X
YouTube

Privacy Policy
Terms of Use
Cookie Settings